Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 1/20 | 0.48 |
| ▸ | MC4R | P32245 | 4/20 | 0.47 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.47 |
| ▸ | IL23R | Q5VWK5 | 7/20 | 0.47 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.47 |
| ▸ | NMUR1 | Q9HB89 | 1/20 | 0.47 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.46 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.45 |
| ▸ | GNPAT | O15228 | 1/20 | 0.45 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30179308 | 1.00 | TFPI (0.48) | TFPIMC4RPTPN2PTPN1IL23R | |
| SCHEMBL30179150 | 1.00 | TFPI (0.48) | TFPIMC4RPTPN2PTPN1IL23R | |
| SCHEMBL30179352 | 1.00 | TFPI (0.48) | TFPIMC4RPTPN2PTPN1IL23R | |
| SCHEMBL30179134 | 0.92 | GNPAT (0.52) | MC4RPTPN2PTPN1FOLH1GNPAT | |
| SCHEMBL30029024 | 0.89 | GNPAT (0.56) | MC4RFOLH1GNPAT | |
| SCHEMBL13388052 | 0.86 | NPY4R (0.58) | TFPIIL23RNMUR2NMUR1NPBWR1 | |
| SCHEMBL29569028 | 0.84 | GNPAT (0.62) | PTPN2PTPN1GNPAT | |
| SCHEMBL31298941 | 0.84 | QRFPR (0.55) | TFPIOPRL1GNPATNPBWR1 | |
| SCHEMBL29568898 | 0.84 | OPRL1 (0.50) | OPRL1 | |
| SCHEMBL29569472 | 0.84 | OPRL1 (0.50) | OPRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230041271-A1 | Mitochondria-Targeted Polypeptide, Preparation Method thereof, and Use thereof | SUN YAT-SEN UNIVERSITY (CN) | 2023-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230041271-A1 | Mitochondria-Targeted Polypeptide, Preparation Method thereof, and Use thereof | MTPN, TIMM13, TIMM10 | TFPI 2430/4885MC4R 819/4885PTPN2 1557/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.